BB Lec - Current Trends Flashcards
Creating RBCs in the laboratory
(blood pharming)
mechanism for forming O-type RBCs
The use of enzymes that remove the carbohydrate moieties of the A and B antigens
Current research on blood substitutes is focused on two areas:
hemoglobin-based oxygen carriers (HBOCs) and per- fluorocarbons (PFCs)
Originally developed to be used in trauma situations such as accidents, combat, and surgery,
RBC substitutes
are intimately involved in primary hemostasis,
Platelets
interaction of platelets and the vascular endothelium in halting and preventing bleeding following vascular injury.
hemostasis
cellular fragments derived from the cytoplasm of megakaryocytes present in the bone marrow.
Platelets
They do not contain a nucleus
Platelets
platelet DNA found in__
mitochondria
average diameter of platelets
2 to 4 μm
normal plt count
150,000 to 350,000 per μL
how many days do PLT circulate
9-12 days
how much plt is sequestered in the microvasculature of the spleen as functional reserves.
30% of the platelets
Used to treat bleeding as associated with thrombocytopenia
PLT
Efficacy of transfused platelets: estimated from __
CORRECTED COUNT INCREMENT
CORRECTED COUNT INCREMENT estimates what of platelets?
Efficacy of transfused platelets:
measured after transfusion; does not evaluate or assess the function of the transfused plt
CCI
Transfused prophylactically to increase the circulating platelet count in hematology-oncology thrombocytopenic patients to prevent bleeding secondary to drug or radiation therapy
PLT
utilized in some instances to treat other disorders in w/c platelets are qualitatively or quantitatively defective because of genetic reasons
PLT
MAJOR PROBLEM whenplatelet transfusions were given as freshly drawn whole blood or platelet-rich plasma
circulatory overload
Today, platelets are prepared as (2)
concentrates from whole blood
by apheresis